Canaan Partners

Founded in 1987, Canaan Partners is a global venture capital firm based in Menlo Park, California. With over $5 billion under management, the firm invests in early-stage technology and healthcare companies worldwide.

Brent Ahrens

General Partner

Brenton Ahrens

General Partner - West Coast

Nandu Anilal

Investor

John Balen

General Partner

Joydeep Bhattacharyya

General Partner

Past deals in Southern US

Diligent Robotics

Venture Round in 2023
Diligent Robotics develops hospital service robots and related AI software to assist clinical and nursing staff with logistical tasks, enabling more time for direct patient care. Its flagship robot, Moxi, operates in hospital environments to handle routine duties and collaborate with humans, supported by AI-based software that enables safe interaction and adaptation to human workflows. Founded in 2017 and based in Austin, Texas, the company seeks to improve patient satisfaction, quality of care, and safety by augmenting healthcare teams with robotic assistance.

OncoResponse

Venture Round in 2023
OncoResponse is an immuno‑oncology biotechnology company that uses a proprietary human antibody platform to discover novel targets and develop fully human monoclonal antibodies for cancer treatment. By interrogating the adaptive immune system of patients who respond exceptionally well to checkpoint inhibition, the company identifies genuine human antibodies against high‑value targets linked with immunosuppressive myeloid biology. Its pipeline aims to alleviate tumor‑microenvironment immunosuppression and enhance immune activation, converting cold tumors into hot ones and providing new therapeutic options for patients.

Papa

Series D in 2021
Papa, Inc. operates an online platform designed to connect college students with senior citizens, facilitating various services to assist older adults in maintaining their independence and well-being. Founded in 2016 and based in Miami, Florida, the platform enables college and nursing students to provide companionship and assistance in areas such as transportation, house chores, technology lessons, grocery shopping, and caregiving. By connecting vetted companions with older adults, Papa aims to enhance social connections and support for seniors, allowing them to live securely and happily at home.

OncoResponse

Series C in 2021
OncoResponse is an immuno‑oncology biotechnology company that uses a proprietary human antibody platform to discover novel targets and develop fully human monoclonal antibodies for cancer treatment. By interrogating the adaptive immune system of patients who respond exceptionally well to checkpoint inhibition, the company identifies genuine human antibodies against high‑value targets linked with immunosuppressive myeloid biology. Its pipeline aims to alleviate tumor‑microenvironment immunosuppression and enhance immune activation, converting cold tumors into hot ones and providing new therapeutic options for patients.

Vineti

Series C in 2020
Vineti, Inc. is a technology company focused on advancing the development and delivery of personalized therapies, particularly in the realm of cell and gene treatments for serious conditions like cancer. Founded in 2016 and headquartered in San Francisco, California, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform integrates various aspects of the therapeutic supply chain, including operations, manufacturing, quality assurance, and regulatory compliance, to streamline and automate processes. It addresses critical challenges faced by patients, healthcare providers, pharmaceutical companies, and regulatory bodies in the commercialization of personalized medicine. By enhancing supply chain orchestration and ensuring compliance with regulatory standards, Vineti aims to expand patient access to innovative therapies. The company also maintains regional offices in Bethesda, Maryland, and Yerevan, Armenia.

Papa

Series B in 2020
Papa, Inc. operates an online platform designed to connect college students with senior citizens, facilitating various services to assist older adults in maintaining their independence and well-being. Founded in 2016 and based in Miami, Florida, the platform enables college and nursing students to provide companionship and assistance in areas such as transportation, house chores, technology lessons, grocery shopping, and caregiving. By connecting vetted companions with older adults, Papa aims to enhance social connections and support for seniors, allowing them to live securely and happily at home.

Vineti

Series C in 2020
Vineti, Inc. is a technology company focused on advancing the development and delivery of personalized therapies, particularly in the realm of cell and gene treatments for serious conditions like cancer. Founded in 2016 and headquartered in San Francisco, California, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform integrates various aspects of the therapeutic supply chain, including operations, manufacturing, quality assurance, and regulatory compliance, to streamline and automate processes. It addresses critical challenges faced by patients, healthcare providers, pharmaceutical companies, and regulatory bodies in the commercialization of personalized medicine. By enhancing supply chain orchestration and ensuring compliance with regulatory standards, Vineti aims to expand patient access to innovative therapies. The company also maintains regional offices in Bethesda, Maryland, and Yerevan, Armenia.

Papa

Series A in 2019
Papa, Inc. operates an online platform designed to connect college students with senior citizens, facilitating various services to assist older adults in maintaining their independence and well-being. Founded in 2016 and based in Miami, Florida, the platform enables college and nursing students to provide companionship and assistance in areas such as transportation, house chores, technology lessons, grocery shopping, and caregiving. By connecting vetted companions with older adults, Papa aims to enhance social connections and support for seniors, allowing them to live securely and happily at home.

Steereo

Seed Round in 2019
Steereo Inc. operates a music discovery platform tailored for rideshare drivers, enabling them to entertain passengers with new music during their journeys. Founded in 2017 and based in New York, the company aims to empower artists by providing them with a unique avenue to market their music and connect with new audiences. Through its application, Steereo facilitates exposure for various artists while offering drivers opportunities to earn additional income and rewards. The service is currently available in key markets such as New York and Austin, Texas, creating impactful brand connections and enhancing the rideshare experience.

ScaleFactor

Series C in 2019
ScaleFactor provides automated accounting and finance software, offering features such as bookkeeping automation, proactive alerts, and business insights translation. It formerly offered additional services like IT integration, HR/payroll, compliance, and CFO advisory. ScaleFactor served various industries including professional services, restaurants, retail, technology, and wellness. The company was founded in 2014 and had offices across North America before ceasing operations.

Players' Lounge

Seed Round in 2019
Players' Lounge Inc., also known as Players' Lounge Online, is a social gaming startup founded in 2016 and based in New Castle, Delaware. The company offers an online platform that allows gamers to compete in e-sports competitions for cash and prizes. Players can connect with others who are interested in playing their favorite video games for monetary rewards, either by challenging individuals directly or participating in organized tournaments. By catering to casual gamers, Players' Lounge provides an accessible opportunity for a wider audience to engage in competitive gaming and potentially earn money, rather than limiting such opportunities to a select few professional players.

Kustomer

Series C in 2019
Founded in 2015, Kustomer develops a SaaS CRM platform for enterprise-level customer service. Its platform unifies data from multiple sources, enabling companies to deliver service through a single timeline view. It serves leading brands such as Ring and Glossier.

ScaleFactor

Series B in 2019
ScaleFactor provides automated accounting and finance software, offering features such as bookkeeping automation, proactive alerts, and business insights translation. It formerly offered additional services like IT integration, HR/payroll, compliance, and CFO advisory. ScaleFactor served various industries including professional services, restaurants, retail, technology, and wellness. The company was founded in 2014 and had offices across North America before ceasing operations.

Bellhops

Series C in 2018
Bellhops, Inc. is a U.S. moving services company that provides loading and unloading for trucks, trailers, storage units, and mobile storage containers, along with heavy lifting. It operates via an online platform and mobile applications that connect customers with movers, enabling local and short- to mid-distance moves for households and businesses. The company emphasizes a technology-enabled model to improve customer experience and pricing transparency, offering booking through a self-service dashboard and a team of movers. Founded in 2013 and based in Chattanooga, Tennessee, Bellhops serves customers across numerous U.S. cities, focusing on small and medium-scale moves and expanding its geographic footprint.

OncoResponse

Series B in 2018
OncoResponse is an immuno‑oncology biotechnology company that uses a proprietary human antibody platform to discover novel targets and develop fully human monoclonal antibodies for cancer treatment. By interrogating the adaptive immune system of patients who respond exceptionally well to checkpoint inhibition, the company identifies genuine human antibodies against high‑value targets linked with immunosuppressive myeloid biology. Its pipeline aims to alleviate tumor‑microenvironment immunosuppression and enhance immune activation, converting cold tumors into hot ones and providing new therapeutic options for patients.

ScaleFactor

Series A in 2018
ScaleFactor provides automated accounting and finance software, offering features such as bookkeeping automation, proactive alerts, and business insights translation. It formerly offered additional services like IT integration, HR/payroll, compliance, and CFO advisory. ScaleFactor served various industries including professional services, restaurants, retail, technology, and wellness. The company was founded in 2014 and had offices across North America before ceasing operations.

Kustomer

Series B in 2018
Founded in 2015, Kustomer develops a SaaS CRM platform for enterprise-level customer service. Its platform unifies data from multiple sources, enabling companies to deliver service through a single timeline view. It serves leading brands such as Ring and Glossier.

Vineti

Series B in 2018
Vineti, Inc. is a technology company focused on advancing the development and delivery of personalized therapies, particularly in the realm of cell and gene treatments for serious conditions like cancer. Founded in 2016 and headquartered in San Francisco, California, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform integrates various aspects of the therapeutic supply chain, including operations, manufacturing, quality assurance, and regulatory compliance, to streamline and automate processes. It addresses critical challenges faced by patients, healthcare providers, pharmaceutical companies, and regulatory bodies in the commercialization of personalized medicine. By enhancing supply chain orchestration and ensuring compliance with regulatory standards, Vineti aims to expand patient access to innovative therapies. The company also maintains regional offices in Bethesda, Maryland, and Yerevan, Armenia.

UrbanSitter

Series C in 2017
Founded in 2010, UrbanSitter operates a childcare marketplace that connects parents with trusted babysitters and nannies recommended by people within their network. The platform also offers services for pet sitting, housekeeping, tutoring, and senior care. With a focus on convenience and reliability, UrbanSitter enables users to book caregivers at short notice.

Cardlytics

Series G in 2017
Cardlytics operates an advertising platform within financial institutions' digital channels, enabling marketers to reach consumers through trusted online and mobile banking channels. It uses purchase-based intelligence to make marketing more relevant and measurable, partnering with over 1,500 financial institutions worldwide.

Kustomer

Series A in 2016
Founded in 2015, Kustomer develops a SaaS CRM platform for enterprise-level customer service. Its platform unifies data from multiple sources, enabling companies to deliver service through a single timeline view. It serves leading brands such as Ring and Glossier.

OncoResponse

Series A in 2016
OncoResponse is an immuno‑oncology biotechnology company that uses a proprietary human antibody platform to discover novel targets and develop fully human monoclonal antibodies for cancer treatment. By interrogating the adaptive immune system of patients who respond exceptionally well to checkpoint inhibition, the company identifies genuine human antibodies against high‑value targets linked with immunosuppressive myeloid biology. Its pipeline aims to alleviate tumor‑microenvironment immunosuppression and enhance immune activation, converting cold tumors into hot ones and providing new therapeutic options for patients.

NextCure

Series A in 2016
NextCure, Inc. is a clinical-stage biopharmaceutical company based in Beltsville, Maryland, that focuses on discovering and developing novel immunomedicines aimed at treating cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate, NC318, is currently undergoing Phase 2 clinical trials for advanced or metastatic solid tumors. Additionally, NextCure is developing NC410, designed to inhibit immune suppression through the modulation of a specific immune receptor. The company is also advancing other product candidates, including LNCB74, an antibody-drug conjugate targeting B7-H4, and is exploring additional immunomodulatory molecules in preclinical stages. NextCure has established collaborations with Yale University for licensing and with Eli Lilly and Company for research and development. Founded in 2015, the company leverages proprietary platforms to identify biologically relevant targets in its pursuit of first-in-class immunotherapy solutions.

Bellhops

Series B in 2015
Bellhops, Inc. is a U.S. moving services company that provides loading and unloading for trucks, trailers, storage units, and mobile storage containers, along with heavy lifting. It operates via an online platform and mobile applications that connect customers with movers, enabling local and short- to mid-distance moves for households and businesses. The company emphasizes a technology-enabled model to improve customer experience and pricing transparency, offering booking through a self-service dashboard and a team of movers. Founded in 2013 and based in Chattanooga, Tennessee, Bellhops serves customers across numerous U.S. cities, focusing on small and medium-scale moves and expanding its geographic footprint.

N-trig

Series H in 2014
N-Trig is a startup specializing in the development of touch screen technologies and pen styluses, aimed at enhancing user interaction with mobile computing devices. Founded in 1999, the company boasts a robust patent portfolio and offers its products across various sectors, including consumer electronics, education, healthcare, graphic design, gaming, and multimedia. N-Trig's Duosense active pen allows users to annotate on screens in a manner akin to writing on paper, while its multi-touch capabilities facilitate direct interaction with devices. The company operates globally, with its research and development center, corporate headquarters, and management based in Kfar Saba, Israel, alongside sales and support offices in Austin, Texas, and San Jose, California. Additionally, N-Trig has operational and supply chain support in Taipei, Tokyo, and Shanghai.

LQ3 Pharmaceuticals

Series A in 2014
LQ3 Pharmaceuticals, Inc. is a healthcare company based in Morrisville, North Carolina, specializing in the development of oral health therapies. Established in 2013, the company employs advanced PRINT (Particle Replication In Non-Wetting Templates) technology to research and create innovative solutions for various oral health issues. By focusing on this niche within the pharmaceutical sector, LQ3 Pharmaceuticals aims to enhance the dental industry through the application of cutting-edge technology and effective therapeutic products.

N-trig

Series G in 2014
N-Trig is a startup specializing in the development of touch screen technologies and pen styluses, aimed at enhancing user interaction with mobile computing devices. Founded in 1999, the company boasts a robust patent portfolio and offers its products across various sectors, including consumer electronics, education, healthcare, graphic design, gaming, and multimedia. N-Trig's Duosense active pen allows users to annotate on screens in a manner akin to writing on paper, while its multi-touch capabilities facilitate direct interaction with devices. The company operates globally, with its research and development center, corporate headquarters, and management based in Kfar Saba, Israel, alongside sales and support offices in Austin, Texas, and San Jose, California. Additionally, N-Trig has operational and supply chain support in Taipei, Tokyo, and Shanghai.

UrbanSitter

Series B in 2014
Founded in 2010, UrbanSitter operates a childcare marketplace that connects parents with trusted babysitters and nannies recommended by people within their network. The platform also offers services for pet sitting, housekeeping, tutoring, and senior care. With a focus on convenience and reliability, UrbanSitter enables users to book caregivers at short notice.

Envisia Therapeutics

Series A in 2013
Envisia Therapeutics Inc. is a company focused on discovering and developing innovative therapies for ophthalmic medical needs. Founded in 2013 and based in Durham, North Carolina, the company utilizes its proprietary Particle Replication In Non-Wetting Templates (PRINT) technology to create a range of particle-based therapies. Envisia is particularly known for its lead product, ENV515, a prostaglandin analogue designed to deliver sustained intraocular pressure reduction for extended periods. In addition to this, the company is developing glaucoma drug therapies that leverage PRINT particle therapeutics to improve drug delivery and efficacy while addressing common barriers faced by existing ocular treatments. As the demand for more effective ocular therapeutics continues to grow, Envisia aims to enhance patient outcomes and convenience in the management of ocular diseases.

Corvium

Series B in 2013
Corvium, Inc. is a food intelligence company that specializes in software solutions for food safety. Founded in 2009 and headquartered in Reston, Virginia, with an additional office in Boston, Massachusetts, Corvium offers its CONTROL-PRO platform, which streamlines the food safety testing lifecycle through visualization, monitoring, analytics, and documentation. This solution aims to reduce the risks of undetected contamination and recalls by minimizing manual tasks prone to errors. In conjunction with its INSIGHTS offering, Corvium provides tailored analysis and continuous monitoring of data flows, aggregating both internal and external information to enhance food safety performance across production facilities. The company's clientele includes food processors, retailers, and consumers, all benefiting from Corvium's commitment to ensuring the safety of food products through robust data management and superior customer service.

N-trig

Series F in 2013
N-Trig is a startup specializing in the development of touch screen technologies and pen styluses, aimed at enhancing user interaction with mobile computing devices. Founded in 1999, the company boasts a robust patent portfolio and offers its products across various sectors, including consumer electronics, education, healthcare, graphic design, gaming, and multimedia. N-Trig's Duosense active pen allows users to annotate on screens in a manner akin to writing on paper, while its multi-touch capabilities facilitate direct interaction with devices. The company operates globally, with its research and development center, corporate headquarters, and management based in Kfar Saba, Israel, alongside sales and support offices in Austin, Texas, and San Jose, California. Additionally, N-Trig has operational and supply chain support in Taipei, Tokyo, and Shanghai.

UrbanSitter

Series A in 2012
Founded in 2010, UrbanSitter operates a childcare marketplace that connects parents with trusted babysitters and nannies recommended by people within their network. The platform also offers services for pet sitting, housekeeping, tutoring, and senior care. With a focus on convenience and reliability, UrbanSitter enables users to book caregivers at short notice.

N-trig

Series E in 2012
N-Trig is a startup specializing in the development of touch screen technologies and pen styluses, aimed at enhancing user interaction with mobile computing devices. Founded in 1999, the company boasts a robust patent portfolio and offers its products across various sectors, including consumer electronics, education, healthcare, graphic design, gaming, and multimedia. N-Trig's Duosense active pen allows users to annotate on screens in a manner akin to writing on paper, while its multi-touch capabilities facilitate direct interaction with devices. The company operates globally, with its research and development center, corporate headquarters, and management based in Kfar Saba, Israel, alongside sales and support offices in Austin, Texas, and San Jose, California. Additionally, N-Trig has operational and supply chain support in Taipei, Tokyo, and Shanghai.

N-trig

Series E in 2011
N-Trig is a startup specializing in the development of touch screen technologies and pen styluses, aimed at enhancing user interaction with mobile computing devices. Founded in 1999, the company boasts a robust patent portfolio and offers its products across various sectors, including consumer electronics, education, healthcare, graphic design, gaming, and multimedia. N-Trig's Duosense active pen allows users to annotate on screens in a manner akin to writing on paper, while its multi-touch capabilities facilitate direct interaction with devices. The company operates globally, with its research and development center, corporate headquarters, and management based in Kfar Saba, Israel, alongside sales and support offices in Austin, Texas, and San Jose, California. Additionally, N-Trig has operational and supply chain support in Taipei, Tokyo, and Shanghai.

UnitedLex

Secondary Market in 2011
Founded in 2006, UnitedLex is a global provider of technology-powered legal and business solutions. It offers services such as litigation support, electronic data discovery, document review, contract management, intellectual property solutions, compliance services, and law department consultancy to corporate clients and law firms worldwide.

Kabam

Series D in 2011
Kabam is an entertainment company that specializes in developing free-to-play games for mobile devices and web platforms. Founded in 2006 and rebranded in 2010, the company is headquartered in San Francisco, California, with additional offices in Los Angeles, Vancouver, Austin, Beijing, London, and Berlin. Kabam offers a diverse portfolio of games, including traditional, social, strategy, action, arcade, sports, and role-playing genres. The company emphasizes the integration of traditional and social gaming elements to create engaging multiplayer experiences, allowing players to enjoy real-time interactions and enhanced gameplay with their friends.

Axial Exchange

Series A in 2011
Axial Exchange is a healthcare technology company that develops a remote patient and population health monitoring and communications platform. The platform delivers real-time insights into patients' health status, data, and behavior to support care teams between encounters, enabling early detection of complications and more engaged patients. Through mobile apps, it facilitates secure sharing of health information with providers and caregivers, with the aim of improving patient outcomes and reducing hospital admissions and overall healthcare costs via early intervention and coordinated care. The company was founded in 2009 and is based in Raleigh, North Carolina.

Chimerix

Series F in 2011
Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, focused on the development of innovative medicines for patients with cancer and serious viral infections. The company is advancing several clinical-stage programs, including dociparstat sodium (DSTAT), a glycosaminoglycan compound aimed at improving outcomes for patients with acute myeloid leukemia during chemotherapy. Another key candidate is brincidofovir (BCV), an antiviral drug being developed as a medical countermeasure for smallpox. Chimerix also leads the development of CMX001, a broad-spectrum antiviral agent targeting life-threatening double-stranded DNA viral infections, currently undergoing multiple clinical studies for use in immunocompromised patients. Additionally, CMX157, an antiviral compound with activity against HIV and hepatitis B, is in development, addressing challenges posed by existing therapies. The company collaborates with various organizations for research and commercialization, deriving revenue from licensing agreements and royalties. Founded in 2000, Chimerix is committed to transforming patient care through its advanced therapeutic candidates.

Kabam

Series C in 2011
Kabam is an entertainment company that specializes in developing free-to-play games for mobile devices and web platforms. Founded in 2006 and rebranded in 2010, the company is headquartered in San Francisco, California, with additional offices in Los Angeles, Vancouver, Austin, Beijing, London, and Berlin. Kabam offers a diverse portfolio of games, including traditional, social, strategy, action, arcade, sports, and role-playing genres. The company emphasizes the integration of traditional and social gaming elements to create engaging multiplayer experiences, allowing players to enjoy real-time interactions and enhanced gameplay with their friends.

Cardlytics

Series C in 2010
Cardlytics operates an advertising platform within financial institutions' digital channels, enabling marketers to reach consumers through trusted online and mobile banking channels. It uses purchase-based intelligence to make marketing more relevant and measurable, partnering with over 1,500 financial institutions worldwide.

Coapt Systems

Debt Financing in 2009
Coapt Systems, Inc. specializes in the design, development, and manufacture of bio-absorbable implants used in soft tissue fixation during facial cosmetic surgery. The company offers a range of products, including the ENDOTINE Forehead 3.0 and ENDOTINE Triple 3.0, which are designed for brow fixation, along with ENDOTINE Midface ST 4.5 for midface suspension. Other offerings include the ENDOTINE Ribbon and various surgical tools such as manual surgical drills and incisionless dissectors for precise application. Coapt's implants are utilized in procedures like forehead lifts, brow lifts, and midface and neck suspensions, catering to the needs of plastic surgeons in enhancing patient outcomes.

Kabam

Series B in 2009
Kabam is an entertainment company that specializes in developing free-to-play games for mobile devices and web platforms. Founded in 2006 and rebranded in 2010, the company is headquartered in San Francisco, California, with additional offices in Los Angeles, Vancouver, Austin, Beijing, London, and Berlin. Kabam offers a diverse portfolio of games, including traditional, social, strategy, action, arcade, sports, and role-playing genres. The company emphasizes the integration of traditional and social gaming elements to create engaging multiplayer experiences, allowing players to enjoy real-time interactions and enhanced gameplay with their friends.

Chimerix

Series E in 2009
Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, focused on the development of innovative medicines for patients with cancer and serious viral infections. The company is advancing several clinical-stage programs, including dociparstat sodium (DSTAT), a glycosaminoglycan compound aimed at improving outcomes for patients with acute myeloid leukemia during chemotherapy. Another key candidate is brincidofovir (BCV), an antiviral drug being developed as a medical countermeasure for smallpox. Chimerix also leads the development of CMX001, a broad-spectrum antiviral agent targeting life-threatening double-stranded DNA viral infections, currently undergoing multiple clinical studies for use in immunocompromised patients. Additionally, CMX157, an antiviral compound with activity against HIV and hepatitis B, is in development, addressing challenges posed by existing therapies. The company collaborates with various organizations for research and commercialization, deriving revenue from licensing agreements and royalties. Founded in 2000, Chimerix is committed to transforming patient care through its advanced therapeutic candidates.

N-trig

Series D in 2009
N-Trig is a startup specializing in the development of touch screen technologies and pen styluses, aimed at enhancing user interaction with mobile computing devices. Founded in 1999, the company boasts a robust patent portfolio and offers its products across various sectors, including consumer electronics, education, healthcare, graphic design, gaming, and multimedia. N-Trig's Duosense active pen allows users to annotate on screens in a manner akin to writing on paper, while its multi-touch capabilities facilitate direct interaction with devices. The company operates globally, with its research and development center, corporate headquarters, and management based in Kfar Saba, Israel, alongside sales and support offices in Austin, Texas, and San Jose, California. Additionally, N-Trig has operational and supply chain support in Taipei, Tokyo, and Shanghai.

UnitedLex

Series B in 2008
Founded in 2006, UnitedLex is a global provider of technology-powered legal and business solutions. It offers services such as litigation support, electronic data discovery, document review, contract management, intellectual property solutions, compliance services, and law department consultancy to corporate clients and law firms worldwide.

Active Network

Private Equity Round in 2008
Active Network is a leading provider of software solutions for activity and event management, facilitating connections between participants and organizers. Founded in 1999 and headquartered in Plano, Texas, the company offers a comprehensive SaaS platform that enables efficient registration, secure payment processing, and data-driven insights to enhance participation and streamline administration. Active Network serves over 27,000 organizers and engages more than 13 million participants globally through its extensive marketplace for activities and events. The company hosts a vast directory of sports and recreational activities, making it easy for users to discover and register for various events, from races to team sports. In addition to registration services, Active Network provides online training tools, community engagement features, and a membership program that offers discounts on sports-related expenses. Its innovative solutions are designed to empower organizations, strengthen communities, and promote a more active lifestyle.

N-trig

Series C in 2008
N-Trig is a startup specializing in the development of touch screen technologies and pen styluses, aimed at enhancing user interaction with mobile computing devices. Founded in 1999, the company boasts a robust patent portfolio and offers its products across various sectors, including consumer electronics, education, healthcare, graphic design, gaming, and multimedia. N-Trig's Duosense active pen allows users to annotate on screens in a manner akin to writing on paper, while its multi-touch capabilities facilitate direct interaction with devices. The company operates globally, with its research and development center, corporate headquarters, and management based in Kfar Saba, Israel, alongside sales and support offices in Austin, Texas, and San Jose, California. Additionally, N-Trig has operational and supply chain support in Taipei, Tokyo, and Shanghai.

Sopherion Therapeutics

Venture Round in 2008
Sopherion Therapeutics, LLC is a privately held biopharmaceutical company based in Princeton, New Jersey, with additional offices in Cheshire, Connecticut, and Estero, Florida, as well as a subsidiary in Toronto, Canada. The company specializes in the development and commercialization of oncology therapies, notably Myocet™, a liposome-encapsulated doxorubicin-citrate complex designed to reduce cardiotoxicity. Sopherion holds an exclusive licensing agreement with Cephalon, Inc. for Myocet™ in the United States and Canada. The firm is currently conducting a Phase III global trial to evaluate Myocet™ in combination with Herceptin® and Taxol for treating invasive, metastatic breast cancer. This trial, which aims to recruit 363 patients across twelve countries, builds on promising Phase II results that demonstrated a 96% response rate and a median progression-free survival of two and a half years. Myocet™ is already registered for use in Canada and Europe in combination with cyclophosphamide for similar indications. Sopherion is also exploring additional oncology agents through its Minicell Peptide Display screening technologies.

Kabam

Series A in 2007
Kabam is an entertainment company that specializes in developing free-to-play games for mobile devices and web platforms. Founded in 2006 and rebranded in 2010, the company is headquartered in San Francisco, California, with additional offices in Los Angeles, Vancouver, Austin, Beijing, London, and Berlin. Kabam offers a diverse portfolio of games, including traditional, social, strategy, action, arcade, sports, and role-playing genres. The company emphasizes the integration of traditional and social gaming elements to create engaging multiplayer experiences, allowing players to enjoy real-time interactions and enhanced gameplay with their friends.

Active Network

Series E in 2007
Active Network is a leading provider of software solutions for activity and event management, facilitating connections between participants and organizers. Founded in 1999 and headquartered in Plano, Texas, the company offers a comprehensive SaaS platform that enables efficient registration, secure payment processing, and data-driven insights to enhance participation and streamline administration. Active Network serves over 27,000 organizers and engages more than 13 million participants globally through its extensive marketplace for activities and events. The company hosts a vast directory of sports and recreational activities, making it easy for users to discover and register for various events, from races to team sports. In addition to registration services, Active Network provides online training tools, community engagement features, and a membership program that offers discounts on sports-related expenses. Its innovative solutions are designed to empower organizations, strengthen communities, and promote a more active lifestyle.

Coapt Systems

Series E in 2007
Coapt Systems, Inc. specializes in the design, development, and manufacture of bio-absorbable implants used in soft tissue fixation during facial cosmetic surgery. The company offers a range of products, including the ENDOTINE Forehead 3.0 and ENDOTINE Triple 3.0, which are designed for brow fixation, along with ENDOTINE Midface ST 4.5 for midface suspension. Other offerings include the ENDOTINE Ribbon and various surgical tools such as manual surgical drills and incisionless dissectors for precise application. Coapt's implants are utilized in procedures like forehead lifts, brow lifts, and midface and neck suspensions, catering to the needs of plastic surgeons in enhancing patient outcomes.

Chimerix

Series D in 2007
Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, focused on the development of innovative medicines for patients with cancer and serious viral infections. The company is advancing several clinical-stage programs, including dociparstat sodium (DSTAT), a glycosaminoglycan compound aimed at improving outcomes for patients with acute myeloid leukemia during chemotherapy. Another key candidate is brincidofovir (BCV), an antiviral drug being developed as a medical countermeasure for smallpox. Chimerix also leads the development of CMX001, a broad-spectrum antiviral agent targeting life-threatening double-stranded DNA viral infections, currently undergoing multiple clinical studies for use in immunocompromised patients. Additionally, CMX157, an antiviral compound with activity against HIV and hepatitis B, is in development, addressing challenges posed by existing therapies. The company collaborates with various organizations for research and commercialization, deriving revenue from licensing agreements and royalties. Founded in 2000, Chimerix is committed to transforming patient care through its advanced therapeutic candidates.

Qovia

Series C in 2006
Qovia is a company that specializes in voice over Internet Protocol (VoIP) telephony monitoring and management technologies. Founded in 2002 and based in Frederick, Maryland, Qovia develops software products designed to monitor and manage voice quality on VoIP telephone systems. Its solutions cater to a diverse range of customers, including school districts, government agencies, law enforcement, banking and financial institutions, call centers, and voice carriers. By leveraging internet technology to enhance voice communication, Qovia positions itself at the forefront of next-generation phone systems.

Everdream

Series F in 2005
Everdream Corporation is a provider of on-demand desktop management software services, specializing in managed services for compliance and uptime. The company offers a comprehensive suite of software solutions that deliver visibility into hardware and software assets, track software license usage, and automate software distribution to ensure regulatory compliance. Additionally, Everdream provides essential protection against Internet attacks, hackers, and data loss through services such as malware protection, patch management, and online data backup. The company also offers IT support solutions, including on-demand employee service desk options and remote control services. Founded in 1998 and headquartered in Fremont, California, Everdream has operational facilities in Dallas, Texas, and Charlotte, North Carolina. It operates as a subsidiary of Dell Inc.

Voyence

Venture Round in 2004
Voyence provides configuration and change management solutions that automate critical change, compliance, and activation processes. The company offers VoyenceControl NG solution, which manages various devices in a heterogeneous infrastructure; automates configuration management lifecycle, including design, change, and compliance; and collects data in its repository, including configuration, asset/hardware, and change and audit information. It offers compliance/security, change/configuration, and extending network management solutions. The company's customers include financial, healthcare, education, government, manufacturing, services, technology, and transportation organizations. Voyence, Inc. was founded in 2000 as PowerUp Networks and it changed its name to Voyence, Inc. in 2003. The company is headquartered in Richardson, Texas.

Active Network

Series C in 2004
Active Network is a leading provider of software solutions for activity and event management, facilitating connections between participants and organizers. Founded in 1999 and headquartered in Plano, Texas, the company offers a comprehensive SaaS platform that enables efficient registration, secure payment processing, and data-driven insights to enhance participation and streamline administration. Active Network serves over 27,000 organizers and engages more than 13 million participants globally through its extensive marketplace for activities and events. The company hosts a vast directory of sports and recreational activities, making it easy for users to discover and register for various events, from races to team sports. In addition to registration services, Active Network provides online training tools, community engagement features, and a membership program that offers discounts on sports-related expenses. Its innovative solutions are designed to empower organizations, strengthen communities, and promote a more active lifestyle.

Sopherion Therapeutics

Series B in 2004
Sopherion Therapeutics, LLC is a privately held biopharmaceutical company based in Princeton, New Jersey, with additional offices in Cheshire, Connecticut, and Estero, Florida, as well as a subsidiary in Toronto, Canada. The company specializes in the development and commercialization of oncology therapies, notably Myocet™, a liposome-encapsulated doxorubicin-citrate complex designed to reduce cardiotoxicity. Sopherion holds an exclusive licensing agreement with Cephalon, Inc. for Myocet™ in the United States and Canada. The firm is currently conducting a Phase III global trial to evaluate Myocet™ in combination with Herceptin® and Taxol for treating invasive, metastatic breast cancer. This trial, which aims to recruit 363 patients across twelve countries, builds on promising Phase II results that demonstrated a 96% response rate and a median progression-free survival of two and a half years. Myocet™ is already registered for use in Canada and Europe in combination with cyclophosphamide for similar indications. Sopherion is also exploring additional oncology agents through its Minicell Peptide Display screening technologies.

Qovia

Series B in 2004
Qovia is a company that specializes in voice over Internet Protocol (VoIP) telephony monitoring and management technologies. Founded in 2002 and based in Frederick, Maryland, Qovia develops software products designed to monitor and manage voice quality on VoIP telephone systems. Its solutions cater to a diverse range of customers, including school districts, government agencies, law enforcement, banking and financial institutions, call centers, and voice carriers. By leveraging internet technology to enhance voice communication, Qovia positions itself at the forefront of next-generation phone systems.

Coapt Systems

Series C in 2003
Coapt Systems, Inc. specializes in the design, development, and manufacture of bio-absorbable implants used in soft tissue fixation during facial cosmetic surgery. The company offers a range of products, including the ENDOTINE Forehead 3.0 and ENDOTINE Triple 3.0, which are designed for brow fixation, along with ENDOTINE Midface ST 4.5 for midface suspension. Other offerings include the ENDOTINE Ribbon and various surgical tools such as manual surgical drills and incisionless dissectors for precise application. Coapt's implants are utilized in procedures like forehead lifts, brow lifts, and midface and neck suspensions, catering to the needs of plastic surgeons in enhancing patient outcomes.

Everdream

Series D in 2003
Everdream Corporation is a provider of on-demand desktop management software services, specializing in managed services for compliance and uptime. The company offers a comprehensive suite of software solutions that deliver visibility into hardware and software assets, track software license usage, and automate software distribution to ensure regulatory compliance. Additionally, Everdream provides essential protection against Internet attacks, hackers, and data loss through services such as malware protection, patch management, and online data backup. The company also offers IT support solutions, including on-demand employee service desk options and remote control services. Founded in 1998 and headquartered in Fremont, California, Everdream has operational facilities in Dallas, Texas, and Charlotte, North Carolina. It operates as a subsidiary of Dell Inc.

Coapt Systems

Series B in 2002
Coapt Systems, Inc. specializes in the design, development, and manufacture of bio-absorbable implants used in soft tissue fixation during facial cosmetic surgery. The company offers a range of products, including the ENDOTINE Forehead 3.0 and ENDOTINE Triple 3.0, which are designed for brow fixation, along with ENDOTINE Midface ST 4.5 for midface suspension. Other offerings include the ENDOTINE Ribbon and various surgical tools such as manual surgical drills and incisionless dissectors for precise application. Coapt's implants are utilized in procedures like forehead lifts, brow lifts, and midface and neck suspensions, catering to the needs of plastic surgeons in enhancing patient outcomes.

Active Network

Series C in 2002
Active Network is a leading provider of software solutions for activity and event management, facilitating connections between participants and organizers. Founded in 1999 and headquartered in Plano, Texas, the company offers a comprehensive SaaS platform that enables efficient registration, secure payment processing, and data-driven insights to enhance participation and streamline administration. Active Network serves over 27,000 organizers and engages more than 13 million participants globally through its extensive marketplace for activities and events. The company hosts a vast directory of sports and recreational activities, making it easy for users to discover and register for various events, from races to team sports. In addition to registration services, Active Network provides online training tools, community engagement features, and a membership program that offers discounts on sports-related expenses. Its innovative solutions are designed to empower organizations, strengthen communities, and promote a more active lifestyle.

Everdream

Series C in 2000
Everdream Corporation is a provider of on-demand desktop management software services, specializing in managed services for compliance and uptime. The company offers a comprehensive suite of software solutions that deliver visibility into hardware and software assets, track software license usage, and automate software distribution to ensure regulatory compliance. Additionally, Everdream provides essential protection against Internet attacks, hackers, and data loss through services such as malware protection, patch management, and online data backup. The company also offers IT support solutions, including on-demand employee service desk options and remote control services. Founded in 1998 and headquartered in Fremont, California, Everdream has operational facilities in Dallas, Texas, and Charlotte, North Carolina. It operates as a subsidiary of Dell Inc.

Everdream

Series B in 2000
Everdream Corporation is a provider of on-demand desktop management software services, specializing in managed services for compliance and uptime. The company offers a comprehensive suite of software solutions that deliver visibility into hardware and software assets, track software license usage, and automate software distribution to ensure regulatory compliance. Additionally, Everdream provides essential protection against Internet attacks, hackers, and data loss through services such as malware protection, patch management, and online data backup. The company also offers IT support solutions, including on-demand employee service desk options and remote control services. Founded in 1998 and headquartered in Fremont, California, Everdream has operational facilities in Dallas, Texas, and Charlotte, North Carolina. It operates as a subsidiary of Dell Inc.

Synchronicity

Venture Round in 2000
Synchronicity is a Charlotte, NC-based creative digital marketing agency that has been delivering professional online strategies, website design, and development services since 1998. The company specializes in creating and promoting high-quality websites, focusing on designing digital platforms and branded experiences that align with client objectives and consumer needs. Synchronicity emphasizes direct collaboration with its clients to craft unique and engaging experiences, helping them solve business challenges and enhance visibility. Additionally, Synchronicity develops software solutions aimed at improving the integrated circuit design process, serving semiconductor and embedded software developers. The company provides design management and collaboration tools that facilitate the handling and distribution of large-scale electronic designs across multiple locations, thereby enhancing design productivity and efficiency for its clients.

Concord Music

Series B in 1996
Concord Music is an independent music and theatrical rights company based in Nashville, Tennessee. The company specializes in the development, management, and acquisition of sound recordings, music publishing, and theatrical performance rights. It represents a diverse array of artistic works, including songs, composed pieces, plays, and musicals. Concord Music is dedicated to managing recorded music activities and publishing music, effectively supporting artists and their creative endeavors. Through its various initiatives, the company aims to foster and promote a rich catalog of music and theatrical content.

Concord Music

Series A in 1995
Concord Music is an independent music and theatrical rights company based in Nashville, Tennessee. The company specializes in the development, management, and acquisition of sound recordings, music publishing, and theatrical performance rights. It represents a diverse array of artistic works, including songs, composed pieces, plays, and musicals. Concord Music is dedicated to managing recorded music activities and publishing music, effectively supporting artists and their creative endeavors. Through its various initiatives, the company aims to foster and promote a rich catalog of music and theatrical content.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.